Atlas Trials

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

Clinical trial NCT07207369 · RECRUITING

Trial details

NCT number
NCT07207369
Sponsor
AbbVie
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acne Scars
Start date
2025-10-24
Primary completion
2029-11-01
Enrollment
395

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.